首页> 外文期刊>Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis >Residual red cell and platelet content in WBC-reduced plasma measured by a novel flow cytometric method.
【24h】

Residual red cell and platelet content in WBC-reduced plasma measured by a novel flow cytometric method.

机译:通过新型流式细胞术测量白细胞减少的血浆中的残留红细胞和血小板含量。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The levels of residual red blood cells (RBC) and platelets (PLT) in WBC-reduced plasma are often below the lower detection limit of automated blood cell counters. This study established a novel flow cytometric method for the enumeration of residual RBC and PLT in plasma. Furthermore, their levels in WBC-reduced plasma prepared by using various filters were investigated. MATERIALS AND METHODS: WBC-reduced plasma was prepared from two sources: (i) filtration of buffy-coat reduced plasma using dock-on Baxter, Pall and Maco Pharma plasma filters; (ii) filtered whole blood using integral Asahi RZ2000, Maco Pharma LST1, NPBI, and Pall WBF2 whole blood filters. Residual RBC and PLT counts were assessed by using a TruCount tube (Becton Dickinson) containing a known number of lyophilized fluorescent beads. RBC and PLT were labelled with dual monoclonal antibodies, anti-CD41-R-phycoerythrin and anti-glycophorin A-fluorescein isothiocyanide, and analyzed by flow cytometer. RESULTS: The flow cytometricmethod used in this method can detect residual RBC, PLT as well as RBC-MV simultaneously. The sensitivity of the assay was 50 x 10(6) cells/l with the coefficient of variations < or = 10%. Baxter and Maco Pharma plasma filters consistently reduced both RBC, RBC-MV and PLT to below 50 x 10(6/)l. Plasma derived from day 1 RZ2000 filtered whole blood contained PLT below 50 x 10(6) cells/l, whereas day 0 NPBI filtered whole blood showed the highest level of residual PLT. CONCLUSION: A sensitive and accurate method for the detection of low levels RBC, RBC-MV, and PLT was established to measure their levels in WBC-reduced plasma. The procedure is simple and practical for routine quality monitoring of plasma, as well as for setting a new specification for WBC-reduced plasma.
机译:背景:减少白细胞的血浆中残留红细胞(RBC)和血小板(PLT)的水平通常低于自动血细胞计数器的检测下限。这项研究建立了一种新颖的流式细胞术方法,用于计数血浆中残留的RBC和PLT。此外,研究了它们在使用各种滤器制备的WBC降低血浆中的含量。材料与方法:减少WBC的血浆可从两种来源制备:(i)使用Dock-on Baxter,Pall和Maco Pharma血浆过滤器过滤血沉棕黄层减少的血浆。 (ii)使用一体的Asahi RZ2000,Maco Pharma LST1,NPBI和Pall WBF2全血过滤器过滤全血。通过使用含有已知数量的冻干荧光珠的TruCount管(Becton Dickinson)评估残留的RBC和PLT计数。用双重单克隆抗体,抗CD41-R-藻红蛋白和抗糖蛋白A-荧光素异硫氰化物标记RBC和PLT,并通过流式细胞仪进行分析。结果:该方法所使用的流式细胞仪可以同时检测残留的RBC,PLT和RBC-MV。测定的灵敏度为50 x 10(6)个细胞/ l,变异系数<或= 10%。百特和Maco Pharma等离子过滤器始终将RBC,RBC-MV和PLT降低到50 x 10(6 /)l以下。从第1天经RZ2000过滤的全血得到的血浆中PLT含量低于50 x 10(6)细胞/ l,而从第0天经过NPBI过滤的全血显示出最高水平的残留PLT。结论:建立了一种灵敏,准确的方法来检测低水平的红细胞,红细胞-MV和PLT,以测量其在白细胞减少的血浆中的水平。该程序对于常规的血浆质量监测以及为WBC降低的血浆设定新的规范非常简单实用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号